AGWCA
IDXX icon

Annis Gardner Whiting Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119
Closed -$66.9K – 766
2026
Q1 		$66.9K Buy
119
+21
+21% +$13.5K 0.01% 527
2025
Q4 		$66.3K Buy
98
+14
+17% +$9.53K 0.01% 482
2025
Q3 		$53.7K Sell
84
-5
-6% -$3.04K 0.01% 490
2025
Q2 		$47.7K Buy
+89
New +$42.6K 0.02% 429
2025
Q1 		– Sell
-6
Closed -$2.48K – 787
2024
Q4 		$2.48K Hold
6
– – ﹤0.01% 673
2024
Q3 		$3.03K Sell
6
-63
-91% -$30.6K ﹤0.01% 677
2024
Q2 		$33.6K Sell
69
-20
-22% -$10K 0.01% 471
2024
Q1 		$48.1K Buy
89
+61
+218% +$33.3K 0.02% 386
2023
Q4 		$15.5K Buy
28
+23
+460% +$10.8K 0.01% 434
2023
Q3 		$2.19K Buy
+5
New +$2.49K ﹤0.01% 609

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's IDXX Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 119 shares — an estimated $66.9K sold.

Annis Gardner Whiting Capital Advisors first reported a position in IDXX in Q3 2023 and held it in 10 quarters. The position peaked at $66.9K in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 119 Idexx Laboratories shares in Q2 2026, an estimated $66.9K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Idexx Laboratories in Q3 2023 and held it in 10 quarters.
  • Annis Gardner Whiting Capital Advisors's Idexx Laboratories position peaked at $66.9K in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.